WHO ICTRP trial
LACunar Intervention Trial 3
ISRCTN44436843 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting
Key facts
| Trial ID | ISRCTN44436843 |
|---|---|
| Public title | LACunar Intervention Trial 3 |
| Scientific title | The LACunar Intervention Trial 3 (LACI-3). Assessment of efficacy and safety of cilostazol and isosorbide mononitrate to prevent adverse outcomes in patients with cerebral small vessel disease (lacunar) ischaemic stroke. |
| Primary sponsor | University of Edinburgh |
| Secondary sponsors | NHS Lothian |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase III |
| Countries | England;Northern Ireland;Scotland;United Kingdom;Wales |
| Conditions | Lacunar (small vessel) ischaemic stroke Nervous System Diseases |
| Interventions | The intervention involves random allocation to one of the four treatment groups, in addition to the guideline standard care after lacunar ischaemic stroke, using an electronic randomisation system: 1. Isosorbide mononitrate (ISMN) oral… |
| Registration date | Dec 24, 2024 |
| Target size | 1300 |
| Secondary IDs | Nil known;Nil known;AC24127 |
| Registry page | isrctn.com |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: